Codexis Announces Completion of CodeEvolver® License Technology Transfer with Global Pharmaceutical Leader
REDWOOD CITY, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading enzyme engineering company enabling the…
Pharmaceuticals, Biotechnology and Life Sciences
REDWOOD CITY, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading enzyme engineering company enabling the…
EMERYVILLE, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Zogenix, a global biopharmaceutical company developing rare disease therapies, and ten U.S.…
Dr. Jack A. Ragheb as Senior Vice President, Translational ScienceMatt Schiller, Head of Business Development GAITHERSBURG, Md., July 14, 2021…
HAMPTON, N.J., July 13, 2021 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the…
CONSHOHOCKEN, Pa., July 13, 2021 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) announced today its first patient dosed in a…
Reduced average 30-day heart failure related costs by $17,753 (p<0.0001) per study subject in FUROSCIX® arm compared to historically matched…
EMERYVILLE, Calif., July 13, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today…
REDWOOD CITY, Calif., July 13, 2021 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive…
Company announcement – No. 46 / 2021 Zealand Pharma A/S – Transaction Under Share Repurchase Program Copenhagen 13 July 2021…
BOSTON, July 13, 2021 (GLOBE NEWSWIRE) — Imara Inc. (the “Company”) (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing…